Novo Nordisk outlays $1.09bn to boost GLP-1RA production in Brazil
Novo Nordisk continues its sizeable manufacturing investments to meet increasing drug demands.
Investment
ABPI calls on UK Government to resolve “VPAG crisis”
Saving shelved ultra-rare therapies through unorthodox funding
Blockbuster potential drugs ruled the 2024 pipeline with 53% rise over 2023
Vaccinex plans Nasdaq exit as Alzheimer market pressure grows
UK M&A activity down in January amid uncertain US opportunities
BIA report: UK biotech investment surged to £3.5bn in 2024
Activist investor Starboard cries foul play in exec U-turn at Pfizer
